321 related articles for article (PubMed ID: 28210010)
1. Evaluation and Treatment of Anemia in Premature Infants.
Hasanbegovic E; Cengic N; Hasanbegovic S; Heljic J; Lutolli I; Begic E
Med Arch; 2016 Dec; 70(6):408-412. PubMed ID: 28210010
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the practice of transfusion in the anemia in preterm infants].
Elguazzar S; Alaoui AM; Izgua AT
Rev Med Brux; 2013; 34(1):4-11. PubMed ID: 23534309
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a restricted transfusion schedule with erythropoietin therapy versus a restricted transfusion schedule alone in very low birth weight premature infants.
Birenbaum HJ; Pane MA; Helou SM; Starr KP
South Med J; 2006 Oct; 99(10):1059-62. PubMed ID: 17100024
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in the treatment of anemia of prematurity.
Chen JY; Wu TS; Chanlai SP
Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
[TBL] [Abstract][Full Text] [Related]
6. Early treatment of premature infants with recombinant human erythropoietin.
Messer J; Haddad J; Donato L; Astruc D; Matis J
Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820
[TBL] [Abstract][Full Text] [Related]
7. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
[TBL] [Abstract][Full Text] [Related]
8. Prediction of transfusions in extremely low-birthweight infants in the erythropoietin era.
Hosono S; Mugishima H; Shimada M; Minato M; Okada T; Takahashi S; Harada K
Pediatr Int; 2006 Dec; 48(6):572-6. PubMed ID: 17168976
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study.
Arif B; Ferhan K
Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870
[TBL] [Abstract][Full Text] [Related]
10. [Criteria for diagnosis and therapy of hyporegeneratory anemia in premature newborns below 33 week of gestation and body weight below 1500 grams].
Pramatarova T; Vakrilova L; Slŭncheva B; Iarŭkova N; Kalaĭdzhieva M; Emilova Z; Shishkova R; Popivanova A; Zhekova N
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():63-6. PubMed ID: 18173017
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with red blood cell transfusions in very-low-birth-weight preterm infants in Brazilian neonatal units.
dos Santos AM; Guinsburg R; de Almeida MF; Procianoy RS; Marba ST; Ferri WA; Rugolo LM; Lopes JM; Moreira ME; Luz JH; González MR; Meneses Jdo A; da Silva RV; Abdallah VO; Duarte JL; Marques PF; Rego MA; Alves Filho N; Krebs VL;
BMC Pediatr; 2015 Sep; 15():113. PubMed ID: 26341125
[TBL] [Abstract][Full Text] [Related]
12. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight].
Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD
An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752
[TBL] [Abstract][Full Text] [Related]
13. [Anemia of prematurity: risk factors influencing red cell transfusions].
Zuppa AA; Mazzotta M; Maragliano G; Girlando P; Florio MG; Tortorolo G
Minerva Pediatr; 1995; 47(1-2):13-8. PubMed ID: 7791703
[TBL] [Abstract][Full Text] [Related]
14. Current controversies in the management of the anemia of prematurity.
Bishara N; Ohls RK
Semin Perinatol; 2009 Feb; 33(1):29-34. PubMed ID: 19167579
[TBL] [Abstract][Full Text] [Related]
15. Issues in transfusing preterm infants in the NICU.
Bain A; Blackburn S
J Perinat Neonatal Nurs; 2004; 18(2):170-82; quiz 183-4. PubMed ID: 15214254
[TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion.
Whyte RK; Kirpalani H; Asztalos EV; Andersen C; Blajchman M; Heddle N; LaCorte M; Robertson CM; Clarke MC; Vincer MJ; Doyle LW; Roberts RS;
Pediatrics; 2009 Jan; 123(1):207-13. PubMed ID: 19117884
[TBL] [Abstract][Full Text] [Related]
17. Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants.
Becquet O; Guyot D; Kuo P; Pawlotsky F; Besnard M; Papouin M; Lapillonne A
BMC Pediatr; 2013 Oct; 13():176. PubMed ID: 24165292
[TBL] [Abstract][Full Text] [Related]
18. Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life.
Testa M; Reali A; Copula M; Pinna B; Birocchi F; Pisu C; Chiappe F
Pediatr Hematol Oncol; 1998; 15(5):415-20. PubMed ID: 9783307
[TBL] [Abstract][Full Text] [Related]
19. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity.
Ohls RK; Christensen RD
J Pediatr; 1991 Nov; 119(5):781-8. PubMed ID: 1941387
[TBL] [Abstract][Full Text] [Related]
20. Transfusion practices in infants receiving assisted ventilation.
Cohen A; Manno C
Clin Perinatol; 1998 Mar; 25(1):97-111. PubMed ID: 9523077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
